Conference Coverage
Conference Coverage
DETERRED trial: Concurrent atezolizumab, CRT shows promise in LA-NSCLC
TORONTO – Concurrent atezolizumab and chemoradiation therapy is safe and showed promising efficacy in LA-NSCLC in...
Conference Coverage
Need blood STAT? Call for a drone
BOSTON – Autonomous unmanned aerial vehicles bring blood to remote hospitals in Africa, but a U.S.-based system will need to overcome significant...
Conference Coverage
MedPAC eyes ‘incident to’ billing
Quality and access to care issues were raised by MedPAC officials and physician groups.
Conference Coverage
Be proactive with prophylaxis to tame VTE
Dr. Jeffrey Weitz offers seven steps to improve prophylaxis in the hospital.
Conference Coverage
ESMO 2018: First look at immunotherapy as first-line treatment for HNSCC
Results of KEYNOTE-048, a study of pembrolizumab for first-line treatment of recurrent or metastatic HNSCC, will be presented at ESMO 2018.
Video
Bias in the clinical setting can impact patient care
Health care providers may harbor implicit, or unconscious, biases that contribute to health care disparities.
Conference Coverage
CT for evaluating pulmonary embolism overused
SAN ANTONIO – Computed tomography may be is overused for evaluation of pulmonary embolism.
Conference Coverage
Updated analysis from JAVELIN Renal 101 to be presented at ESMO 2018
The phase 3 trial compared immunotherapy in combination with a tyrosine kinase inhibitor to sunitinib montherapy as first-line therapy for...
Conference Coverage
Updated ThroLy system predicts need for thromboprophylaxis
DUBROVNIK, CROATIA – The revised ThroLy scoring system offers a lymphoma-specific system to predict thromboembolic events.
Conference Coverage
Increased incidence of GI, colorectal cancers seen in young, obese patients
PHILADELPHIA – Obese patients of all ages had higher rates of colorectal cancer resections and differing age ranges had higher rates of other GI...
Conference Coverage
GARFIELD-AF registry: DOACs cut mortality 19%
MUNICH – Results from a worldwide registry with more than 26,000 atrial fibrillation patients showed better survival with a direct oral...